Results from a Phase 2 trial of Covaxin indicate that it is safe and well tolerated, while unpublished interim results from the Phase 3 trial indicate that the vaccine has 78 per cent efficacy against symptomatic disease.
Miya Ponsetto's lawyer pleaded not guilty to the charges claiming his client was a "distraught and panicked young woman stranded without her lifeline, her phone, thousands of miles from home."